Comparing different therapies for Helicobacter pylori eradication
Official title: Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy, Vonoprazan-amoxicillin Dual Therapy and Proton Pump Inhibitor-based Standard Triple Therapy in the First-line Anti-H. Pylori Treatment
Run by Kaohsiung Medical University · NCT06349486 · Data updated 2026-11-12
This study is testing three different treatment plans to see which one works best for adults with Helicobacter pylori infection.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 390 (estimated) |
| Sponsor | Kaohsiung Medical University Academic / other |
| Locations | 1 site (Kaohsiung City) |
| Status | Recruiting |
| Started | November 28, 2023 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | January 15, 2026 |
| Trial ID | NCT06349486 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who are infected with Helicobacter pylori.
✕Probably not a fit
Patients who have previously undergone treatment for Helicobacter pylori or have certain medical conditions, such as severe liver cirrhosis or malignancies, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial aims to compare the effectiveness and safety of three different treatment regimens for Helicobacter pylori infection: a 14-day bismuth-amoxicillin-vonoprazan triple therapy, a 14-day vonoprazan dual therapy, and a 14-day rabeprazole triple therapy. The study will recruit 780 adult patients from ten medical centers in Taiwan and will utilize a randomized, open-label design. Participants will be monitored for drug adherence and adverse events, with H. pylori status assessed through a breath test six weeks post-treatment. The trial will also explore the impact of antibiotic resistance and specific genetic factors on treatment efficacy.
Why it matters
Potential benefit: If successful, this study could provide more effective treatment options for patients with Helicobacter pylori infection.
How similar studies have gone: Other studies have shown varying success with different treatment regimens for Helicobacter pylori, making this approach both relevant and necessary.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: (1) At least 18 years old. (2) Subjects infected with Helicobacter pylori. Exclusion Criteria: 1. Those who have ever received Helicobacter pylori sterilization treatment. 2. Those who are allergic to the drugs used in this research. 3. Those who have had stomach surgery. 4. Those with severe liver cirrhosis or uremia or malignant tumors. 5. Women who are pregnant or breastfeeding.
Where it's running
-
Kaohsiung Medical University Hospital
Kaohsiung City, Taiwan Recruiting
Study contacts
- Study coordinator: Deng-Chyang Wu, MD, PHD
- Email: dechwu@yahoo.com
- Phone: 88673121101
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Bismuth-amoxicillin-vonoprazan triple therapy versus bismuth-based quadruple therapy for H. pylori infection
This will test whether a 14-day bismuth-amoxicillin-vonoprazan triple therapy works better and is as safe as a 14-day bismuth-based quadruple therapy for adults with H. pylori infection.
-
Interactive e-book training to improve home care nurses' pressure injury care
This project will test whether an interactive online e-book helps home care nurses learn more and feel more confident when preventing and treating pressure injuries.
-
Immediate effects of progressive muscle relaxation on brain waves
This will test whether a single session of progressive muscle relaxation quickly changes brain wave patterns in healthy adults.
-
Program to help older adults living alone recover from limb injuries
This study tests a new program led by nurse practitioners to help older adults living alone recover from limb injuries and improve their overall health and well-being.
-
Immediate TENS on calf muscle or sympathetic ganglion to boost popliteal blood flow
This trial will test whether TENS applied to the calf muscle or thoracolumbar sympathetic ganglia at two different frequencies can immediately increase blood flow behind the knee in healthy adults with normal BMI.
-
Comparing injections for treating rotator cuff tears
This study is testing three different injection treatments for shoulder pain from rotator cuff tears to see which one helps people feel better and recover faster.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.